Project 3: A Multilevel HPV Self-Testing Intervention to Increase Cervical Cancer Screening among Women in Appalachia
Project 3: A Multilevel HPV Self-Testing Intervention to Increase Cervical Cancer Screening among Women in Appalachia
批准号:
10627811
负责人:
Paul L Reiter
金额:
$15.66万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
未结题
起止时间:
2019-04-11 至 2025-03-31
关键词:
AddressAgeAppalachian RegionAppointmentAreaAttitudeAustraliaBeliefCaringCervical Cancer ScreeningCharacteristicsClientClinicCountryCytologyDevicesEducationEffectivenessEffectiveness of InterventionsEligibility DeterminationFocus GroupsFutureGeographic LocationsGoalsGuidelinesHPV-High RiskHealth PersonnelHealth systemHealthy People 2020HomeHuman PapillomavirusHuman papilloma virus infectionIntegrated Health Care SystemsInternationalInterventionIntervention TrialKnowledgeMalignant neoplasm of cervix uteriMissionNetherlandsOncogenicOutcomePap smearPatientsPersonsPilot ProjectsPrevention programProviderPublic HealthRecommendationReportingResearchResearch PrioritySamplingScientific Advances and AccomplishmentsService delivery modelServicesSurveysSystemTestingUnited StatesUnited States Preventative Services Task ForceWomanWomen&aposs HealthWorkbarrier to carecancer health disparitycervical cancer preventioncervicovaginalcost effectivecost effectivenesseffectiveness evaluationeffectiveness/implementation hybridevidence basefollow-uphealth organizationhigh riskimplementation interventionimplementation outcomesimplementation researchimprovedinnovationinsightpatient navigationpatient navigatorpatient orientedprevention serviceprimary outcomeprogramsruralitysatisfactionscreeningscreening guidelinesscreening policyscreening programself testinguptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY – PROJECT 3
Most cases of cervical cancer occur among unscreened and under screened women. Strategies to increase
screening among these women, including HPV self-testing, have therefore been identified as the most
important cervical cancer screening research priority. HPV self-testing involves women using a device to
collect their own cervicovaginal sample for HPV testing. International studies have repeatedly shown that many
unscreened and under screened women will use an HPV self-test at home and return it by mail, and recent
efforts in the United States (US), including our own work, have established the feasibility of implementing such
mail-based programs. An important next step in this field of research is to examine the effectiveness and
implementation of a large, mail-based HPV self-testing program in the US.
The overall goal of the proposed project is to determine the effectiveness and implementation of a multi-level
cervical cancer screening intervention that features HPV self-testing for unscreened and under screened
women from Appalachia, a region with longstanding cervical cancer disparities. The intervention will include
mail-based HPV self-testing (patient-level), healthcare provider education sessions about HPV self-testing
(provider-level), and patient navigation for women who do not initially return their HPV self-test or who
subsequently test positive for a high-risk (i.e., oncogenic) HPV infection (system-level). The proposed study will
include 1180 unscreened and under screened Appalachian women who are ages 30-64 and be implemented
as part of the integrated health system-based cervical cancer prevention program “Improving Uptake of
Cervical Cancer Prevention Services in Appalachia.”
Importantly, the proposed project will take an effectiveness-implementation hybrid approach that will allow for
the assessment of both intervention effectiveness and implementation. Specific aims will address each
outcome type (service, implementation, and client outcomes) recommended for implementation research: Aim
1 (service outcomes) will determine the effectiveness of the multi-level intervention in increasing cervical
cancer screening (primary outcome); Aim 2 (implementation outcomes) will assess the acceptability, fidelity,
sustainability, and cost-effectiveness of the intervention; and Aim 3 (client outcomes) will determine satisfaction
with the intervention at the patient-, provider-, and system-level. Each aim will make a significant research
contribution and, taken together, will be one of the most innovative and comprehensive HPV self-testing efforts
to date in the US. As HPV self-testing continues to emerge as a cervical cancer screening strategy in the US,
these findings will provide an evidence base on both intervention effectiveness and implementation that will be
highly valuable in guiding future HPV self-testing programs and cervical cancer screening policies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 3: A Multilevel HPV Self-Testing Intervention to Increase Cervical Cancer Screening among Women in Appalachia
-
批准号:10381632
-
项目类别:
-
资助金额:$21.59万
-
财政年份:2019
-
负责人:Paul L Reiter
-
依托单位:
Project 3: A Multilevel HPV Self-Testing Intervention to Increase Cervical Cancer Screening among Women in Appalachia
-
批准号:10268466
-
项目类别:
-
资助金额:$33.61万
-
财政年份:2019
-
负责人:Paul L Reiter
-
依托单位:
Project 3: A Multilevel HPV Self-Testing Intervention to Increase Cervical Cancer Screening among Women in Appalachia
-
批准号:10268454
-
项目类别:
-
资助金额:$1.01万
-
财政年份:2019
-
负责人:Paul L Reiter
-
依托单位:
A Randomized Controlled Trial of an HPV Vaccine Intervention for Young Sexual Minority Men
-
批准号:10620370
-
项目类别:
-
资助金额:$51.84万
-
财政年份:2018
-
负责人:Paul L Reiter
-
依托单位:
A Secondary Analysis to Identify HPV Vaccination Disparities across Hispanic Subgroups in the United States
-
批准号:9768550
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2018
-
负责人:Paul L Reiter
-
依托单位:
A Randomized Controlled Trial of an HPV Vaccine Intervention for Young Sexual Minority Men
-
批准号:10669810
-
项目类别:
-
资助金额:$49.03万
-
财政年份:2018
-
负责人:Paul L Reiter
-
依托单位:
Project 3: A Multilevel HPV Self-Testing Intervention to Increase Cervical Cancer Screening among Women in Appalachia
-
批准号:9913510
-
项目类别:
-
资助金额:$21.28万
-
财政年份:--
-
负责人:Paul L Reiter
-
依托单位:
Behavioral Measurement Shared Resource
-
批准号:9000505
-
项目类别:
-
资助金额:$12.83万
-
财政年份:--
-
负责人:Paul L Reiter
-
依托单位:
Behavioral Measurement Shared Resource
-
批准号:9221251
-
项目类别:
-
资助金额:$8.62万
-
财政年份:--
-
负责人:Paul L Reiter
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: